The dilemma of ICD implant testing (Q36802666)

16 August 2017

1 reference

title

The dilemma of ICD implant testing (English)

1 reference

16 August 2017

Charles D Swerdlow

1

1 reference

PubMed ID

17461879

16 August 2017

Andrea M Russo

series ordinal

2

1 reference

PubMed ID

17461879

16 August 2017

Paul J Degroot

series ordinal

3

1 reference

16 August 2017

1 May 2007

1 reference

Pacing and Clinical Electrophysiology

16 August 2017

1 reference

16 August 2017

30

1 reference

16 August 2017

675-700

1 reference

16 August 2017

5

1 reference

Defibrillation threshold: clinical utility and therapeutic implications

16 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Measurement of ventricular electrogram amplitude during intraoperative induction of ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Implantation of cardioverter defibrillators without induction of ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Advanced ICD troubleshooting: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Undersensing of VF in a patient with optimal R wave sensing during sinus rhythm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Current concepts of ventricular defibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

The ventricular defibrillation and upper limit of vulnerability dose-response curves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Comparison of the defibrillation threshold and the upper limit of ventricular vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Effect of rapid pacing and T-wave scanning on the relation between the defibrillation and upper-limit-of-vulnerability dose-response curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Relation between upper limit of vulnerability and defibrillation threshold in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Comparative reproducibility of defibrillation threshold and upper limit of vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

The impact of catecholamines on defibrillation threshold in patients with implanted cardioverter defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Ischemic ventricular fibrillation: The importance of being spontaneous

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Effect of duration of ventricular fibrillation on defibrillation efficacy in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) tria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

High defibrillation thresholds in transvenous biphasic implantable defibrillators: clinical predictors and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Clinical predictors of transvenous defibrillation energy requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Shortening the second phase duration of biphasic shocks: effects of class III antiarrhythmic drugs on defibrillation efficacy in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Present understanding of shock polarity for internal defibrillation: the obvious and non-obvious clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: a practical guide to patient treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Effects of chronic amiodarone therapy on defibrillation threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Effects of lidocaine on relation between defibrillation threshold and upper limit of vulnerability in open-chest dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Halothane, isoflurane, and fentanyl increase the minimally effective defibrillation threshold of an implantable cardioverter defibrillator: first report in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on ventricular defibrillation threshold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

The zone of vulnerability to T wave shocks in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Effect of shock waveform on relationship between upper limit of vulnerability and defibrillation threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Changes in cerebral oxygen uptake and cerebral electrical activity during defibrillation threshold testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

Electrophysiologist-implanted transvenous cardioverter defibrillators using local versus general anesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-8159.2007.00730.X

10.1111/J.1540-8159.2007.00730.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17461879